Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Alibaba's Historic $2.8bn Fine Signals Coming Antitrust Wave In China
Pharma Industry Group Prioritizes Compliance
Apr 12 2021
•
By
Brian Yang
HISTORIC ALIBABA FINE SIGNALS NEW WAVE OF ANTITRUST LITIGATION • Source: Shutterstock
More from China
More from Focus On Asia